Chicago IL 神经母细胞瘤临床试验
7项针对 神经母细胞瘤的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
招募中1/2 期
- Lurie Children's Hospital-Chicago, Chicago
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
招募中3 期
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
招募中观察性研究
- Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute, Chicago
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
招募中3 期
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Lurie Children's Hospital-Chicago, Chicago
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
招募中2 期
- Comer Children's Hospital, University of Chicago, Chicago
Neuroblastoma Biology Study
招募中观察性研究
- University of Chicago, Comer Children's Hospital, Chicago
其他城市的 神经母细胞瘤试验
- Boston, MA13 项研究
- New York City, NY12 项研究
- Washington, DC11 项研究
- Dallas, TX10 项研究
- Cincinnati, OH9 项研究
- St. Louis, MO9 项研究
- Memphis, TN9 项研究
- Philadelphia, PA9 项研究
- Aurora, CO9 项研究
- Hartford, CT8 项研究
- Birmingham, AL8 项研究
- Harrisburg, PA8 项研究
Chicago的其他研究
- 乳腺癌59 项研究
- 非小细胞肺癌59 项研究
- 癌症（所有类型）51 项研究
- 前列腺癌45 项研究
- 肺癌43 项研究
- 转移性癌症42 项研究
- 肥胖症40 项研究
- 卵巢癌36 项研究
- 结直肠癌32 项研究
- 卒中31 项研究
- 头颈鳞状细胞癌29 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。